Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery

Abstract

IMPORTANCEPerioperative cardiovascular complications occur in 3% of hospitalizations for noncardiac surgery in the US. This review summarizes evidence regarding cardiovascular risk assessment prior to noncardiac surgery.OBSERVATIONS Preoperative cardiovascular risk assessment requires a focused history and physical examination to identify signs and symptoms of ischemic heart disease, heart failure, and severe valvular disease. Risk calculators, such as the Revised Cardiac Risk Index, identify individuals with low risk (<1%) and higher risk (Ն1%) for perioperative major adverse cardiovascular events during the surgical hospital admission or within 30 days of surgery. Cardiovascular testing is rarely indicated in patients at low risk for major adverse cardiovascular events. Stress testing may be considered in patients at higher risk (determined by the inability to climb Ն2 flights of stairs, which is <4 metabolic equivalent tasks) if the results from the testing would change the perioperative medical, anesthesia, or surgical approaches. Routine coronary revascularization does not reduce perioperative risk and should not be performed without specific indications independent of planned surgery. Routine perioperative use of low-dose aspirin (100 mg/d) does not decrease cardiovascular events but does increase surgical bleeding. Statins are associated with fewer postoperative cardiovascular complications and lower mortality (1.8% vs 2.3% without statin use; P < .001) in observational studies, and should be considered preoperatively in patients with atherosclerotic cardiovascular disease undergoing vascular surgery. High-dose β-blockers (eg, 100 mg of metoprolol succinate) administered 2 to 4 hours prior to surgery are associated with a higher risk of stroke (1.0% vs 0.5% without β-blocker use; P = .005) and mortality (3.1% vs 2.3% without β-blocker use; P = .03) and should not be routinely used. There is a greater risk of perioperative myocardial infarction and major adverse cardiovascular events in adults aged 75 years or older (9.5% vs 4.8% for younger adults; P < .001) and in patients with coronary stents (8.9% vs 1.5% for those without stents; P < .001) and these patients warrant careful preoperative consideration.CONCLUSIONS AND RELEVANCE Comprehensive history, physical examination, and assessment of functional capacity during daily life should be performed prior to noncardiac surgery to assess cardiovascular risk. Cardiovascular testing is rarely indicated in patients with a low risk of major adverse cardiovascular events, but may be useful in patients with poor functional capacity (<4 metabolic equivalent tasks) undergoing high-risk surgery if test results would change therapy independent of the planned surgery. Perioperative medical therapy should be prescribed based on patient-specific risk.

Statin therapy and postoperative short‐term mortality after rectal cancer surgery

“…This may be explained by the proposed reparative effects of statins on endothelial cells. There is a body of evidence in the literature to support this claim [4].…”

“…A fraction of these complications are presumed to be amplified by the immediate stress response initiated by the surgical trauma [2]. This may not only give rise to surgical complications but also adverse medical events of infectious, cardiovascular, respiratory and cerebral origin [3][4][5][6]. Such nonsurgical postoperative problems predispose this surgical patient group to a higher mortality rate.…”

Investigational study of the clinical characteristics of confirmed COVID-19 cases

“…It is necessary to perform a comprehensive history and physical examination prior to surgery especially for those populations undergoing high-risk surgery. Although cardiovascular testing is seldom recommended with a low-risk surgery, it should be advised on patient-specific risk [ 24 ].…”

Integrating ECG Monitoring and Classification via IoT and Deep Neural Networks

“…Among stable patients undergoing non-urgent and noncardiac major surgery, the index can identify patients with a higher risk of complications. The index may help identify candidates for non-invasive techniques or other management strategies for further risk stratification [13]. Lee, et al studied 4315 patients aged ≥ 50, then developed and validated an index risk for cardiac complications [14].…”